_med.jpg)
INDIANAPOLIS, Dec. 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced a $3 billion expansion of the Kenosha County, Wisconsin, manufacturing facility that the company acquired earlier this year.
The Wisconsin Biohealth Tech Hub, led by BioForward Wisconsin, achieves a significant milestone as a Phase 2 recipient of the U.S. Department of Commerce’s Economic Development Administration (EDA) Regional Technology and Innovations Hub (Tech Hub) program, affirming Wisconsin’s leadership in biohealth technology and personalized medicine.
INDIANAPOLIS and LINCOLNSHIRE, Ill., April 22, 2024 – Eli Lilly and Company (NYSE: LLY) and Nexus Pharmaceuticals, LLC today announced a definitive agreement for Lilly to acquire a manufacturing facility from Nexus, a leading sterile manufacturer in the pharmaceutical industry.
Project Metrics INDUSTRY Pharmaceutical Manufacturing DIRECT JOBS 200 CAPITAL EXPENDITURE $250 million REAL ESTATE 15 acres, 200,000 square feet LOCATION Pleasant Prairie, Wisconsin “M7 did an excellent job communicating the Wisconsin value proposition, which factored importantly into our decision to site our new production operation in Pleasant